203
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Functional and immune response to respiratory syncytial virus infection in aged BALB/c mice: A search for genes determining disease severity

, , , , , & show all
Pages 40-49 | Received 16 Aug 2013, Accepted 22 Oct 2013, Published online: 19 Dec 2013

REFERENCES

  • Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ: Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997. J Infect Dis. 2001 Jan 1;183(1):16–22. Epub 2000 Nov 10.
  • Shay DK, Holman RC, Newman RD, Liu LL, STOUT JW, Anderson LJ: Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA. 1999;282:1440–1446.
  • Holman RC, Shay DK, Curns AT, Lingappa JR, Anderson LJ: Risk factors for bronchiolitis associated deaths among infants in the United States. Pediatr Infect Dis J. 2003;22:483–490.
  • Dowell SF, Anderson LJ, Gary HE Jr, Erdman DD, Plouffe JF, File TM Jr, Marston BJ, Breiman RF: Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis. 1996;174(3):456–462.
  • Falsey AR, Cunningham CK, Barker WH, Kouides RW, Yuen JB, Menegus M, Weiner LB, Bonville CA, Betts RF: Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis. 1995;172(2):389–394.
  • Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE: Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749–1759.
  • Drinka PJ, Gravenstein S, Krause P, Langer EH, Barthels L, Dissing M, Shult P, Schilling M: Non-influenza respiratory viruses may overlap and obscure influenza activity. J Am Geriatr Soc. 1999;47(9):1087–1093.
  • Drinka PJ, Gravenstein S, Langer E, Krause P, Shult P: Mortality following isolation of various respiratory viruses in nursing home residents. Infect Control Hosp Epidemiol. 1999;20(12):812–815.
  • Walsh EE, Falsey AR: Age-related differences in humoral immune response to respiratory syncytial virus infection in adults. J Med Virol. 2004;73(2):295–299.
  • Mbawuike I, Acuna C, Walz K, Atmar R, Greenberg S, Couch R: Cytokines and impaired CD8+CTL activity among elderly persons and the enhancing effect of IL-12. Mech Ageing Dev. 1997;94(1–3):25–39.
  • Powers DC. Influenza A virus-specific cytotoxic T lymphocyte activity declines with advancing age. J Am Geriatr Soc. 1993;41(1):1–5.
  • Falsey AR, Walsh EE: Humoral immunity to respiratory syncytial virus infection in the elderly. J Med Virol. 1992;36(1):39– 43.
  • Falsey AR, Walsh EE. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults. J Infect Dis. 1998;177(2):463–466.
  • Lüsebrink J, Wiese C, Thiel A, Tillmann R-L, Ditt V, Müller A, Schildgen O, Schildgen V: High seroprevalance of neutralizing capacity against human metapneumovirus in all age groups studied in Bonn, Germany. Clin Vacc Immunol. 2010 17(3):481–484.
  • Anderson LJ, Tsou C, Potter C, Keyserling HL, Smith TF, Ananaba G, Bangham CR: Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J Infect Dis. 1994;170(5):1201–1208.
  • Román M, Calhoun WJ, Hinton KL, Avendaño LF, Simon V, Escobar AM, Gaggero A, Díaz PV.. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J RespirCrit Care Med. 1997;156(1):190–195.
  • Sheeran P, Jafri H, Carubelli C, Saavedra J, Johnson C, Krisher K, Sánchez PJ, Ramilo O: Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J. 1999;18(2):115–122.
  • Janssen R, Pennings J, Hodemaekers H, Buisman A, van Oosten M, de Rond L, Oztürk K, Dormans J, Kimman T, Hoebee B: Host transcription profiles upon primary respiratory syncytial virus infection. J Virol. 2007;81(11):5958–5967. Epub 2007 Mar 21.
  • Zhang Y, Wang Y, Gilmore X, Xu K, Wyde PR, Mbawuike IN: An aged mouse model for RSV infection and diminished CD8+ CTL responses. ExpBiol Med (Maywood). 2002;227(2):133–140.
  • Liu B, Kimura Y: Local immune response to respiratory syncytial virus infection is diminished in senescence-accelerated mice. J Gen Virol. 2007;88(Pt 9):2552–2558.
  • Ditt V, Lüsebrink J, Tillmann RL, Schildgen V, Schildgen O: Respiratory infections by HMPV and RSV are clinically indistinguishable but induce different host response in aged individuals. PLoS ONE. 6(1):e16314. doi:10.1371/journal.pone.0016314
  • Fulton RB, Weiss KA, Pewe LL, Harty JT, Varga SM: Aged mice exhibit a severely diminished CD8 T cell response following respiratory syncytial virus infection. J Virol. 2013;87(23):12694–12700. Epub 2013 Sep 18.
  • Wang H, Peters N, Schwarze J: Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J Immunol. 2006;177(9):6263–6270.
  • Reith W, LeibundGut-Landmann S, Waldburger JM: Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol. 2005;5(10):793–806.
  • Handunnetthi L, Ramagopalan SV, Ebers GC, Knight JC: Regulation of major histocompatibility complex class II gene expression, genetic variation and disease. Genes Immun. 2010;11(2):99–112. Epub 2009 Nov 5.
  • Pai RK, Convery M, Hamilton TA, Boom WH, Harding CV: Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J Immunol. 2003;171:175–184.
  • Pennini ME, Pai RK, Schultz DC, Boom WH, Harding CV: Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. J Immunol. 2006;176:4323–4330.
  • Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ. Aging and innate immune cells. J LeukocBiol. 2004;76:291–299.
  • Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S: Cutting edge: impaired Toll-like receptor expression and function in aging. J Immunol. 2002;169:4697–4701.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.